The ADAMTS1–EGFR cyclic axis serves as a promoter of tumor metastasis in RCC, with TIMP3, VCAN, and p53 being critical determinants involved in the execution of the prometastatic effect of the ADAMTS1–EGFR axis. Here, TP53 is linked to renal cell carcinoma.